Research Progress of Stimuli Responsive Nanocarriers in Diagnosis and Treatment of Cancer
DOI:
Author:
Affiliation:

Key Laboratory for Nanomedicine of Guangdong Medical University, Dongguan Key Laboratory of Drug Design and Formulation Technology, Guangdong Medical University; CAS Key Laboratory of Health Informatics, Guangdong Key Laboratory of Nanomedicine, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen,CAS Key Laboratory of Health Informatics, Guangdong Key Laboratory of Nanomedicine, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen,Key Laboratory for Nanomedicine of Guangdong Medical University, Dongguan Key Laboratory of Drug Design and Formulation Technology, Guangdong Medical University; CAS Key Laboratory of Health Informatics, Guangdong Key Laboratory of Nanomedicine, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen,Key Laboratory for Nanomedicine of Guangdong Medical University, Dongguan Key Laboratory of Drug Design and Formulation Technology, Guangdong Medical University; CAS Key Laboratory of Health Informatics, Guangdong Key Laboratory of Nanomedicine, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen,CAS Key Laboratory of Health Informatics, Guangdong Key Laboratory of Nanomedicine, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen,Key Laboratory for Nanomedicine of Guangdong Medical University, Dongguan Key Laboratory of Drug Design and Formulation Technology, Guangdong Medical University,Key Laboratory for Nanomedicine of Guangdong Medical University, Dongguan Key Laboratory of Drug Design and Formulation Technology, Guangdong Medical University,CAS Key Laboratory of Health Informatics, Guangdong Key Laboratory of Nanomedicine, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen

Clc Number:

Fund Project:

This work was supported by grants from The National Natural Science Foundation of China (21375141, 81401509, 81371679, 21404115, 81401520 and 21701033), Key International S&T Cooperation Project (2015DFH50230), Natural Science Foundation of Guangdong Province (2017A030313079, 2017A030313726), Dongguan Project on Social Science and Technology Development (2015108101019), Chinese Postdoctoral Project (2017M612803) and Science Foundation of Guangdong Medical University (M2016006)

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Stimuli responsive nanocarriers as nano-intelligent drug delivery system could make corresponding change in structure and physicochemical properties for response to external stimulus.Take the advantages of avoiding premature drug release and improving the drug concentration in the lesion, they have become a focus in diagnosis and treatment of cancer and were widely used to control drug delivery and release.Based on the temperature, magnetic field, ultrasonic, light, pH and other endogenous and endogenous stimulus, we reviewed the recent research development of stimuli responsive nanocarriers in the field of tumor diagnosis and treatment in this paper.

    Reference
    Related
    Cited by
Get Citation

TIAN Hao, ZHAO Peng-Fei, ZHENG Ming-Bin, MA Ai-Qing, LUO Zhen-Yu, CHEN Shi-Chun, LU Cheng-Yu, CAI Lin-Tao. Research Progress of Stimuli Responsive Nanocarriers in Diagnosis and Treatment of Cancer[J]. Progress in Biochemistry and Biophysics,2018,45(6):593-600

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:October 20,2017
  • Revised:April 25,2018
  • Accepted:April 26,2018
  • Online: April 27,2018
  • Published: June 20,2018